Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bergthorsson, Jon Thor
MetadataShow full item record
CitationTeodorescu P, Pasca S, Jurj A, Gafencu G, Joelsson JP, Selicean S, et al. Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis. J Cell Mol Med. 2020 Oct;24(19):11100-11110. doi: 10.1111/jcmm.15526
AbstractPrimary myelofibrosis (PMF) is a Ph-negative myeloproliferative neoplasm (MPN), characterized by advanced bone marrow fibrosis and extramedullary haematopoiesis. The bone marrow fibrosis results from excessive proliferation of fibroblasts that are influenced by several cytokines in the microenvironment, of which transforming growth factor-β (TGF-β) is the most important. Micromechanics related to the niche has not yet been elucidated. In this study, we hypothesized that mechanical stress modulates TGF-β signalling leading to further activation and subsequent proliferation and invasion of bone marrow fibroblasts, thus showing the important role of micromechanics in the development and progression of PMF, both in the bone marrow and in extramedullary sites. Using three PMF-derived fibroblast cell lines and transforming growth factor-β receptor (TGFBR) 1 and 2 knock-down PMF-derived fibroblasts, we showed that mechanical stress does stimulate the collagen synthesis by the fibroblasts in patients with myelofibrosis, through the TGFBR1, which however seems to be activated through alternative pathways, other than TGFBR2. Keywords: TGF-β; fibroblast activation; invasion; micromechanics; myelofibrosis; proliferation.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download
Rights© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
- Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.
- Authors: Agarwal A, Morrone K, Bartenstein M, Zhao ZJ, Verma A, Goel S
- Issue date: 2016
- Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
- Authors: Bock O, Höftmann J, Theophile K, Hussein K, Wiese B, Schlué J, Kreipe H
- Issue date: 2008 Apr
- Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.
- Authors: Bock O, Muth M, Theophile K, Winter M, Hussein K, Büsche G, Kröger N, Kreipe H
- Issue date: 2009 Sep
- Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.
- Authors: Ciaffoni F, Cassella E, Varricchio L, Massa M, Barosi G, Migliaccio AR
- Issue date: 2015 Mar
- Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
- Authors: Nakayama S, Yokote T, Hiraoka N, Akioka T, Nishiwaki U, Miyoshi T, Iwaki K, Fumimoto A, Masuda Y, Hatooka J, Fujimoto M, Nishimura Y, Tsuji M
- Issue date: 2017 Apr